PZW mitigated hepatic fibrosis, with its effect associated with the inhibition of the IL-6/JAK2/STAT3 and TGF-β/Smad2/3 signaling pathways and through raising the MMP1/TIMP-1 ratio. The gene discussed is STAT3; the disease is Hepatic fibrosis.